我们如何治疗由于酸盐激酶缺乏症导致的溶血性贫血症
Sara Tama-Shekan1, Valeria Moreno1, Ludovic Saba1
1Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
Hematology reports
|September 23, 2024
概括
在大多数患者中,米塔皮瓦特有效治疗酸盐激酶 (PK) 缺乏性贫血,改善血红蛋白,减少输血. 然而,并非所有患有PK缺乏症的人都对这种疾病修饰药物有反应.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 酸盐激酶 (PK) 缺乏症是一种遗传性疾病,导致红细胞 (RBC) 中的慢性溶血性贫血.
- 症状包括贫血,疲劳,黄和潜在的并发症,如胆结石和铁过载.
- 目前的管理重点是缓解症状和输血红细胞.
研究的目的:
- 描述了三例用mitapivat治疗的PK缺乏性贫血病.
- 概述这种罕见的血溶性疾病的现代管理策略.
- 为了评估有效性和患者对治疗的反应.
主要方法:
- 一个医疗保健数据库的回顾性分析.
- 整合定量和定性研究方法.
- 分析治疗结果的案例研究方法.
主要成果:
- 三分之二的患者对mitapivat有积极反应,血红蛋白增加和输血需求减少.
- 一名患有特定PKLR基因突变的患者没有对mitapivat反应.
- 治疗反应因患者个体因素而异,包括基因型.
结论:
- 米塔皮瓦特是第一个批准用于PK缺乏症的疾病修饰药物,满足了许多患者未满足的需求.
- 并非所有患有PK缺乏症的患者都能从缓解治疗中获得治疗效益.
- 基因型和表型应指导治疗治疗的治疗决策.
相关概念视频
Fates of Pyruvate
8.4K
Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
8.4K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
146
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
146
Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


